Skip to main content
OpenTrials
Completed

NCT Number: NCT02938208

An Investigation to Test a Prototype Full-face Mask in the Home Setting

This investigation is a prospective non-blinded and non-randomized clinical investigation. This investigation is designed to evaluate the performance (leak and comfort) as well as participant's overall acceptance of the Jupiter mask amongst OSA participants. A total number of up to 15 OSA participants who currently use full face masks will be recruited for the trial.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Fisher & Paykel Healthcare, Auckland, New Zealand

Loading trial locations.

About this study

This investigation is designed to evaluate the performance (leak and comfort) as well as participant's overall acceptance of the Jupiter mask amongst OSA participants. A total number of up to 15 OSA participants who currently use full face masks will be recruited for the trial. The participants will be recruited from the Fisher and Paykel Healthcare Database of subjects with OSA (Ethics reference NTY/08/06/064), Auckland District Health Board (ADHB), or WellSleep Centre (Bowen Hospital, Wellington, NZ).

Participants will be on the trial for 21 days ± 6 days, using the prototypes at home for 14 days ± 3 days. PAP baseline data on the participant's prescribed treatment pressure with their usual mask and will be collected for 7 days ± 3 days prior to mask fitting with the Jupiter trial mask.

Fisher and Paykel Healthcare will act as the investigator and sponsor for this investigation. This study will be conducted in accordance with ICH/GCP Guidelines. No deviation from the protocol will be implemented without prior review and approval of the sponsor except where it may be necessary to eliminate an immediate hazard to a research participant. In such case, the deviation will be reported to the sponsor (Bhavi Ogra) as soon as possible.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18+ years of age
  • Diagnosed with OSA by a practicing physician
  • Prescribed PAP therapy (Bi-Level or Continuous Positive Airway Pressure (CPAP) or Automatic Positive Airway Pressure (APAP)). Patient can be naïve to CPAP therapy or experienced (6 months and more)
  • Existing full face mask users
  • Patients who are able to put on and remove their current mask without gross difficulty relating to an existing condition (e.g. arthritis of the hands).

Exclusion criteria

  • Inability to give informed consent
  • Anatomical or physiological conditions making PAP therapy inappropriate (e.g unconsolidated facial fracture)
  • Commercial Drivers who are investigated by New Zealand Transport Agency (NZTA)
  • Current diagnosis of CO2 retention
  • Pregnant or think they may be pregnant

Treatment and study plan

Jupiter Full Face Mask

Device

Full Face Mask for the treatment of obstructive sleep apnea (OSA) using CPAP therapy.

Primary outcomes

  1. Objective mask leak data measurement (System Leak)

    Time frame: Up to 21 ± 6 days in-home

    Obtained from participant's CPAP device, measured in L/min

  2. Subjective Measurement of leak assessed using a Subjective Questionnaire

    Time frame: Up to 21 ± 6 days in-home

    Subjective Questionnaire

  3. Comfort assessed using a Subjective Questionnaire

    Time frame: Up to 21 ± 6 days in-home

    Subjective Questionnaire

  4. Stability assessed using a Subjective Questionnaire

    Time frame: Up to 21 ± 6 days in-home

    Subjective Questionnaire

  5. Draft assessed using a Subjective Questionnaire

    Time frame: Up to 21 ± 6 days in-home

    Subjective Questionnaire

  6. Noise assessed using a Subjective Questionnaire

    Time frame: Up to 21 ± 6 days in-home

    Subjective Questionnaire

Secondary outcomes

  1. Preference of Mask assessed using a Subjective Questionnaire

    Time frame: Up to 21 ± 6 days in-home

    Subjective Questionnaire

  2. Usability via mask unboxing/fitting exercise with a subjective questionnaire

    Time frame: Up to 21 ± 6 days in-home

    Usability activity during visit 2 with subjective questionnaire after activity

Sponsors and collaborators

Lead sponsor

Fisher and Paykel Healthcare

Industry

Registry information

Important dates

Study start
2016
Primary completion
2016
Study completion
2017
First posted
Oct 19, 2016
Registry last updated
Jul 25, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.